Online citations, reference lists, and bibliographies.

Design Of Drugs Through A Consideration Of Drug Metabolism And Pharmacokinetics

D. Smith
Published 2010 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
SummaryDrug metabolism input to the discovery process has been to date largely on an empirical case by case basis. Considerable advances have been made, such that basic rules can be applied to the behaviour of a compound in man based on physico-chemistry and structure. This is particularly true in the area of the cytochrome P-450 enzymes, the principal enzymes involved in the primary clearance of drugs. The major human forms, CYP2D6, CYP2C9 and CYP3A4 all have distinct substrate preferences which are being catalogued and rationalised. Such understandings will not only impact on existing drugs. Since the enzymes and systems will remain the same, these understandings can be applied to the design of molecules for the targets of the future, whilst the structure activity relationships of those targets are being researched and revealed.
This paper references
10.3109/00498259209053137
Role of metabolism and pharmacokinetic studies in the discovery of new drugs--present and future perspectives.
M. J. Humphrey (1992)
Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem.
L. Pichard (1990)
10.3109/00498259209051873
Bioanalytical data in decision making: discovery and development.
D. Smith (1992)
10.3109/00498259009046838
Design of toxicokinetic studies.
D. Smith (1990)
10.1111/j.1365-2125.1988.tb03318.x
Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985).
R. A. Prentis (1988)
10.3109/00498258809041669
Distribution coefficient, a convenient term for the relation of predictable physico-chemical properties to metabolic processes.
C. Manners (1988)
10.1016/0006-2952(92)90333-E
Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes.
D. Smith (1992)
10.1021/JM00056A005
Studies directed toward the design of orally active renin inhibitors. 1. Some factors influencing the absorption of small peptides.
S. Rosenberg (1993)
10.1096/fasebj.4.8.2185971
Mechanisms of cytochrome P‐450 catalysis
F. Guengerich (1990)
10.1021/JM00067A002
(S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.
P. Stjernlöf (1993)
Clinical pharmacokinetics of non-steroidal antiinflammatory drugs, Clinical Pharmacokinetics
R. K. Verbeck (1983)
10.1021/jm00082a018
Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.
D. Floyd (1992)
10.1002/chin.198747159
Synthesis of a Series of Compounds Related to Betaxolol, a New β1-Adrenoceptor Antagonist with a Pharmacological and Pharmacokinetic Profile Optimized for the Treatment of Chronic Cardiovascular Diseases.
Philippe Manoury (1987)
Identification of
Hua (2000)
10.1023/A:1015882030289
Desolvation Energy: A Major Determinant of Absorption, But Not Clearance, of Peptides in Rats
Michael S. Karls (2004)
Structure activity and drug metabolism studies leading to potent antihypertensive agents
D. M. Floyd (1992)
10.1016/1056-8719(93)90054-I
The use of in vitro metabolism studies in the understanding of new drugs.
S. H. Chiu (1993)
Pharmacokineticpharmacodynamic relationships of oral hypoglaecemic agents
P Marchetti (1989)
Metabolism of non-steroidal anti-inflammatory drugs by cytochrome P-4502C
A. J. Newlands (1992)
10.1021/jo00300a010
Active site dynamics of toluene hydroxylation by cytochrome P-450
R. Hanzlik (1990)
10.1021/JM00061A004
Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies.
G. Strobl (1993)
Putative active site template model for cytochrome P4502C9 (tolbutamide hydroxylase).
B. Jones (1996)
10.1097/00008571-199302000-00001
Predicting the cytochrome P450 mediated metabolism of xenobiotics.
K. Korzekwa (1993)
Predicting the Cytochrome P-450 mediated metabolism
Korzekwa (1993)



This paper is referenced by
10.13005/ojc/340535
Synthesis of a New Conjugates of Imidazole wih Beta Lactam Moiety and Evaluation of its Expanded Antibacterial Activity
Sarmd D. Noori (2018)
10.1016/j.addr.2007.08.043
Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.
J. Custodio (2008)
Estudo fitoquímico e propriedades biológicas da Dipteryx alata Vogel (baru)
Rodolfo Sánchez (2014)
Developments in drug delivery technologies : molecular and crystal design, cellular response and targeted and site-specific delivery : review article
M. M. Villiers (2003)
Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
G. Geromichalos (2016)
10.3109/03602532.2013.767345
Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights
S. P. Tripathi (2013)
10.2174/157340609790170533
Synthesis, cytotoxic evaluation and in silico pharmacokinetic prediction of some benzo[a]phenazine-5-sulfonic acid derivatives.
N. S. Hari Narayana Moorthy (2009)
10.1177/096032719701600108
9. In Vitro Strategies for Predicting Biokinetics and Systemic Toxicity
(1997)
10.1124/dmd.112.046995
In Vitro Studies on the Oxidative Metabolism of 20(S)-Ginsenoside Rh2 in Human, Monkey, Dog, Rat, and Mouse Liver Microsomes, and Human Liver S9
L. Li (2012)
10.1007/s00044-014-1040-y
Synthesis, characterization and preliminary anticonvulsant evaluation of some flavanone incorporated semicarbazides
Chandra Shekhar Sharma (2014)
Semantic Scholar Logo Some data provided by SemanticScholar